Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

127 results about "Structural difference" patented technology

Array substrate

The invention provides an array substrate. Each sub-pixel in the array substrate comprises a control thin film transistor and a pixel electrode electrically connected with the control thin film transistor. Each pixel electrode comprises a main region pixel electrode, an auxiliary region pixel electrode and a first connecting electrode, wherein the main region pixel electrode and the auxiliary region pixel electrode are arranged in a spaced mode, and the first connecting electrode is electrically connected with the main region pixel electrode and the auxiliary region pixel electrode. The main region pixel electrodes and the auxiliary region pixel electrodes are slit electrodes shaped like a Chinese character 'mi'. The width of main region branch electrodes of the main region pixel electrodes is smaller than that of auxiliary region branch electrodes of the auxiliary region pixel electrodes, and the width of main region slits of the main region pixel electrodes is smaller than that of auxiliary region slits of the auxiliary region pixel electrodes. Color cast can be relieved through the structural difference of the main region pixel electrodes and the auxiliary region pixel electrodes, the number of TFTs in the sub-pixels is reduced, the opening rate of the pixels is increased, and the difficulty of optimal common voltage balance regulation and control of main regions and auxiliary regions is reduced.
Owner:SHENZHEN CHINA STAR OPTOELECTRONICS SEMICON DISPLAY TECH CO LTD

Equipment cross-version upgrading method and device

InactiveCN103995854AAvoid the problem of dynamic loss caused by non-inheritanceVersion upgrade implementationProgram loading/initiatingSpecial data processing applicationsDatabase fileStructural difference
The invention provides an equipment cross-version upgrading method and device. The method comprises the following steps that a first database file corresponding to an older-version data table in a database is generated; new-version software runs, a new-version data table corresponding to the new-version software is established in the database, and operation on the new-version data table is received in real time; a second database file corresponding to the new-version data table is generated; table structural information stored in the first database file and table structural information stored in the second database file are compared to obtain table structural difference information; data in the new-version data table are generated according to the table structural difference information and data in the older-version data table in the first database file; the data in the generated new-version data table are imported into the new-version data table. According to the equipment cross-version upgrading method and device, the data generated in the upgrading process can be inherited in real time, version upgrading in equipment is further achieved, and the redundant version upgrading processing procedure is avoided.
Owner:DATANG MOBILE COMM EQUIP CO LTD

Small molecule compositions for binding to hsp90

Structural differences in binding pockets of members of the HSP90 family can be exploited to achieve differential degradation of kinases and other signaling proteins through the use of designed small molecules which interact with the N-terminal binding pocket with an affinity which is greater than ADP and different from the ansamycin antibiotics for at least one species of the HSP90 family. Moreover, these small molecules can be designed to be soluble in aqueous media, thus providing a further advantage over the use of ansamycin antibiotics. Pharmaceutical compositions can be formulated containing a pharmaceutically acceptable carrier and a molecule that includes a binding moiety which binds to the N-terminal pocket of at least one member of the HSP90 family of proteins. Such binding moieties were found to have antiproliferative activity against tumor cells which are dependent on proteins requiring chaperones of the HSP90 family for their function. Different chemical species have different activity, however, allowing the selection of, for example Her2 degradation without degradation of Raf kinase. Thus, the binding moieties possess an inherent targeting capacity. In addition, the small molecules can be linked to targeting moieties to provide targeting of the activity to specific classes of cells. Thus, the invention further provides a method for treatment of diseases, including cancers, by administration of these compositions. Dimeric forms of the binding moieties may also be employed.
Owner:SLOAN KETTERING INST FOR CANCER RES

Well logging characterization method, well drilling layer section selecting method and well drilling layer section selecting device of a sand body structure

The invention provides a well logging characterization method, a well drilling layer section selecting method and a well drilling layer section selecting device of a sand body structure. The well drilling layer section selecting method comprises the steps of S1, selecting sampling point data of a natural gamma-ray well logging curve in a needed processing layer section and calculating a smooth degree GS of the natural gamma-ray well logging curve; S2, calculating an average value of shale contents in the processing layer section; S3, building a formula, which is as shown in the attached drawing, of well logging characterization parameters Pss of the sand body structure; S4, comparing the sand body structure differences of different processing layer sections according to Pss values, and selecting a processing section in a minimum Pss value as an optimized layer section; S5, carrying out optimization and well drilling development on an oil gas enrichment area of the sand structure according to the optimized layer section. The well logging characterization method, the well drilling layer section selecting method and the well drilling layer section selecting device of the sand body structure, provided by the invention can be used for quantitatively comparing the differences of reservoir sand body structures, have the advantages of simpleness, intuition, high distinguishing degree, good reliability and the like, and are capable of supplying technical support to the optimization and the well drilling development of the oil gas enrichment area in densification oil gas.
Owner:PETROCHINA CO LTD

Sodium nitroprusside-conjugated medicine-carrying prussian blue analogue nano-photothermal therapeutic agent and preparation method thereof

The invention discloses a sodium nitroprusside-conjugated medicine-carrying prussian blue analogue nano-photothermal therapeutic agent and a preparation method thereof. The particle size of the sodiumnitroprusside-conjugated medicine-carrying prussian blue analogue nano-photothermal therapeutic agent prepared by a hydrothermal reaction method is 205.4nm, and passive targeting can be achieved by means of an enhanced permeability and retention (EPR) effect of a tumor site. Under the illumination of near-infrared laser, the nano-photothermal therapeutic agent can not only induce photothermal ablation of tumor cells through excellent photothermal conversion efficiency, but also can control NO release, thereby improving the EPR effect and increasing intratumoral delivery of nanoparticles. Furthermore, the NO can also inhibit tumor progression by inducing apoptosis of the tumor cells, preventing angiogenesis, reversing multidrug resistance, and the like. On the other hand, due to the structural difference between sodium nitroprusside and potassium ferricyanide, the lattice defects of the nanoparticles are caused, and the drug loading capacity of the nano-photothermal therapeutic agent is accordingly increased. Therefore, after chemotherapeutic drugs are carried, under the irradiation of near-infrared light, the nano-photothermal therapeutic agent can realize dose-controlled NO release and phototherapy and chemotherapy combined oncotherapy. In addition, the sodium nitroprusside-conjugated medicine-carrying prussian blue analogue nano-photothermal therapeutic agent provided by theinvention also has good photothermal stability and certain photoacoustic contrast properties.
Owner:CHONGQING MEDICAL UNIVERSITY

Method for manufacturing GH4169 low pressure turbine box forging with flange

The invention belongs to the technical field of forgings preparation, and particularly relates to a method for manufacturing a GH4169 low pressure turbine box forging with a flange. The method that part of a blank film is divided and broken into shape is adopted for manufacturing the GH4169 low pressure turbine box forging with the flange. The method comprises the following steps of sawing, preheating, upsetting, punching, reaming of a mandrel supporter, dividing and breaking forming the part of the blank film, and breaking forming. The GH4169 low pressure turbine box forging with the flange manufactured by the method has the advantages that the outer dimensions meet the manufacturing requirements of parts, and the forming is easy; the machining removal process has a smaller margin, the integrity of the forging flow line is maintained, and the subsequent manufacturing is in short cycle, so that the material utilization rate is high; the internal structure is uniform without need of welding, so that the structural differences and deformation problems caused by welding are solved; the tensile properties at room temperature and 650 DEG C is high and the long-lasting performance is great at 650 DEG C and 690 MPa, so that the technical requirements of aeroengine low-pressure turbines are met, and the margin is large.
Owner:GUIZHOU AVIATION TECHN DEV

A transfer learning method from macro expression to micro expression

The invention relates to a transfer learning method from macro expression to micro expression, in the process of training, the model adopts subspace projection, the micro-expression feature matrix andmacro-expression feature matrix are projected into a common subspace, and the macro-expression feature matrix is used to reconstruct the micro-expression feature matrix. The macro-expression and micro-expression features and structural differences in the common subspace are minimized by imposing constraints to maximize the correlation between macro-expression and micro-expression in the subspace,and the target projection matrix is iteratively optimized. Finally, the test set data are projected to the common subspace using the target projection matrix and classified by KNN. The useful information of the existing macro-expression domain samples is transferred to the micro-expression domain, which is equivalent to expanding the number of labeled micro-expression samples, thus overcoming thedisadvantage that the micro-expression samples are difficult to label. This method not only reduces the waste of label manpower, but also greatly improves the recognition performance and provides another strategy for micro-expression recognition.
Owner:SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products